Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
fluoxetine (prozac) (1 trial)
hydroxychloroquine (plaquenil) (1 trial)
paroxetine (paxil) (1 trial)
sertraline (zoloft) (1 trial)
venlafaxine (effexor) (1 trial)
anastrozole (arimidex) (1 trial)
exemestane (aromasin) (1 trial)
fulvestrant (faslodex) (1 trial)
letrozole (femara) (2 trials)
palbociclib (ibrance) (1 trial)
pertuzumab (perjeta) (1 trial)
trastuzumab (herceptin) (1 trial)
zonisamide (Zonegran) (1 trial)
cannabis (1 trial)
cimetidine (tagamet) (1 trial)
cinnamon (1 trial)
dextromethorphan (delsym) (1 trial)
furosemide (lasix) (2 trials)
goldenseal (1 trial)
hydrastis canadensis (1 trial)
metformin (glucophage) (2 trials)
midazolam (versed) (3 trials)
moon kratom yellow (1 trial)
nicotine (nicorette) (1 trial)
procaine benzylpenicillin (novocaine) (1 trial)
rosuvastatin (crestor) (1 trial)
tetrahydrocannabinol (1 trial)
vitamin c (1 trial)
methylsulfonylmethane (1 trial)
Breast Neoplasms (Phase 3)
Diabetic Neuropathies (Phase 1)
Peripheral Nervous System Diseases (Phase 1)
Pneumonia (Phase 4)
Trials (12 total)
Trial APIs (29 total)